WARWICK, RI--(Marketwire - July 12, 2011) -
Biomedical Structures, LLC (BMS), a provider of biomedical textiles for medical devices and other advanced clinical applications, today announced that it recently completed the highest quarter of growth in company history.
Following its March 2011 acquisition of medical textile manufacturer Concordia Medical, BMS has experienced a steady increase in demand for its textile development expertise for the next generation of medical devices. Additionally, BMS has capitalized on its record-breaking capital growth by further building out its textile processing capabilities for improved capacity to serve its core and growing list of customers. These efforts, which include the doubling of knitting capabilities, tripling of non-woven capacity, and quadrupling of weaving capacity for the production of biomedical textiles, have enabled BMS to notch its highest investment quarter ever, and are a continuation of the company's planned path of growth initiated by a 2010 funding from Ampersand Ventures.
With the addition of the former Concordia's manufacturing and cleanroom facilities, BMS' production has expanded in volume and scope, and will continue to widen to meet device OEM demands, particularly in the development and application of felt scaffolds and other absorbable non-woven technologies designed for tissue engineering and regrowth applications in a variety of therapeutic sectors.
Biomedical Structures specializes in the advanced design and manufacturing of biomedical textiles with expertise in knitting, braiding, weaving, and non-woven technology. The company utilizes a growing variety of implantable-grade absorbable and non-absorbable biomaterials in orthopedic, general surgery, tissue engineering, cardiovascular, bariatric, cosmetic surgery, and veterinary applications, including implantable devices and drug delivery technologies.
"2011 has been an exciting year for BMS," said Biomedical Structures CEO and President John Gray. "Our acquisition of Concordia Medical has enabled us to deliver at improved speed, volume, and scope for our medical device customers, and this second quarter is a direct reflection of that added ability. We are looking forward to continuing to build our scientific expertise by expanding our engineering resources and bringing the unique and innovative properties of textiles to our customers as they develop the next generation of medical devices."
About Biomedical Structures
Biomedical Structures LLC specializes in the advanced design, development and manufacturing of biomedical textiles for device manufacturers in the orthopedic, cardiovascular, general surgery, and tissue engineering and regenerative medicine markets. With specialized expertise in bio-polymer fabrication techniques, Biomedical Structures is enabling innovative implantable devices and other breakthrough medical applications. ISO 13485 registered, Biomedical Structures is a trusted outsourcing partner providing a full line of services from concept design to full-scale production, supply chain management, and post-manufacturing sterilization and packaging. For more information, visit www.bmsri.com.